BDBM223494 US10407441, Compound JQ33::US9320741, JQ33

SMILES Cc1sc-2c(c1C)C(=NC(CC(=O)NCCN1CCOCC1)c1nnc(C)n-21)c1ccc(Cl)cc1

InChI Key InChIKey=KULOTNHGHJGDQB-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 223494   

TargetBromodomain-containing protein 4(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM223494(US9320741, JQ33 | US10407441, Compound JQ33)
Affinity DataIC50: 85nMpH: 7.4 T: 2°CAssay Description:BRD4(1): Assays were performed as described previously with minor modifications from the manufacturer's protocol (PerkinElmer, USA). All reagents wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBromodomain-containing protein 4(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM223494(US9320741, JQ33 | US10407441, Compound JQ33)
Affinity DataIC50: 29.5nMpH: 7.4 T: 2°CAssay Description:BRD4(2): Assays were performed as described previously with minor modifications from the manufacturer's protocol (PerkinElmer, USA). All reagents wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBromodomain-containing protein 4 [75-147](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM223494(US9320741, JQ33 | US10407441, Compound JQ33)
Affinity DataIC50: 85nMAssay Description:All reagents were diluted in 50 mM HEPES, 100 mM NaCl, 0.1% BSA, pH 7.4 supplemented with 0.05% CHAPS and allowed to equilibrate to room temperature ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBromodomain-containing protein 4 [368-440](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM223494(US9320741, JQ33 | US10407441, Compound JQ33)
Affinity DataIC50: 29.5nMAssay Description:All reagents were diluted in 50 mM HEPES, 100 mM NaCl, 0.1% BSA, pH 7.4 supplemented with 0.05% CHAPS and allowed to equilibrate to room temperature ...More data for this Ligand-Target Pair
In DepthDetails
US Patent